Medicina
Departamento
University of Leeds
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Leeds (46)
2024
-
Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: Insights from the international prospective ACVC-EAPCI EORP NSTEMI registry
Age and Ageing, Vol. 53, Núm. 8
-
Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology
European Heart Journal: Acute Cardiovascular Care, Vol. 13, Núm. 1, pp. 36-45
2023
-
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15
2022
-
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
The Lancet Rheumatology, Vol. 4, Núm. 11, pp. e785-e794
2021
-
2020 Update of the quality indicators for acute myocardial infarction: A position paper of the Association for Acute Cardiovascular Care: The study group for quality indicators from the ACVC and the NSTE-ACS guideline group
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 224-233
-
The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 207-215
2020
-
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
Blood, Vol. 136, Núm. 26, pp. 3033-3040
-
Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
Anaerobe, Vol. 62
-
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study
Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694
-
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
The Lancet Rheumatology, Vol. 2, Núm. 2, pp. e71-e83
-
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test
Diagnostic Microbiology and Infectious Disease, Vol. 98, Núm. 4
2019
-
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
JAMA network open, Vol. 2, Núm. 9, pp. e1911750
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656
2018
-
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834
-
Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
European heart journal. Acute cardiovascular care
-
Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction
European Heart Journal, Vol. 39, Núm. 42, pp. 3798-3806
-
Indications and practical approach to non-invasive ventilation in acute heart failure
European Heart Journal, Vol. 39, Núm. 1, pp. 17-25
-
Inflammatory bowel disease and Clostridium difficile infection: Contrasting views of international clinical professionals
Zeitschrift fur Gastroenterologie, Vol. 56, Núm. 7, pp. 731-737
-
Maintenance Treatment and Survival in Patients with Myeloma: A Systematic Review and Network Meta-analysis
JAMA Oncology, Vol. 4, Núm. 10, pp. 1389-1397